Effect of First Line Gastric Cancer Chemotherapy Regime on the AGS Cell Line - MTT Assay Results

Alizadeh-Navaei, Reza; Rafiei, Alireza; Abedian-Kenari, Saeid; Asgarian-Omran, Hossein; Valadan, Reza; Hedayatizadeh-Omran, Akbar

추천

검색

자료유형: 학술저널

저자정보: Alizadeh-Navaei, Reza (Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences) Rafiei, Alireza (Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences) Abedian-Kenari, Saeid (Immunogenetic Research Center, Mazandaran University of Medical Sciences) Asgarian-Omran, Hossein (Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences) Valadan, Reza (Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences) Hedayatizadeh-Omran, Akbar (Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제17권 제1호

발행연도: 2016.1

수록면: 131 - 133 (3page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: Combination chemotherapy regimes are common treatments for cancer. The aim of this study was to evaluation the effect of individual chemotherapeutic agents in comparison with a first line chemotherapy regime treatment in the AGS gastric cancer cell line by MTT assay. Materials and Methods: In this experimental study, AGS cells were grown in RPMI-1640 supplemented with 10% fetal calf serum and 100 IU/ml penicillin, and $10{\mu}g/ml$ streptomycinin, under a humidified condition at $37^{\circ}C$ with 5% CO2. All cells were washed with PBS and detached with trypsin, centrifuged and 8000 cells re-plated on to 96- well plates. LD50 doses of Epirubicin, Cisplatin and 5-fluorouracil were added to each well in mono or triple therapy. Anti-proliferative activities were determined by MTT assay after 24, 48 or 72 h. Results: Results of MTT assays showed that there were no significant differences among 3 drugs in monotherapy (p=0.088), but there was significant difference between combination therapy with epirubicin (P=0.031) and 5FU (p=0.013) on cell survival at 24 h. After 48 and 72 hours, cell viability showed significant differences between the 3 drugs (p=0.048 and P=0.000 for 48 and 72 h, respectively) and there was significant difference between combination therapy with epirubicin (P=0.035 and P=0.002 for 48 and 72 h, respectively). Conclusions: The results showed no significant differences between these chemotherapy drugs each given alone, but combination therapy with 3 drugs had significant effects on cell viability in comparison with epirubicin alone.

#Gastric cancer #chemotherapy #AGS cell line #MTT #monotherapy #combined therapy

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!